These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 11112989)
41. Effects on Ca2+ uptake of monoclonal antibodies raised against canine cardiac phospholamban and their correlation with epitopic location. Morris GL; Wang JH Adv Exp Med Biol; 1992; 311():417. PubMed ID: 1382364 [No Abstract] [Full Text] [Related]
42. Depletion of sarcoplasmic reticulum calcium prompts phosphorylation of phospholamban to stimulate store refilling. Bhogal MS; Colyer J Ann N Y Acad Sci; 1998 Sep; 853():260-3. PubMed ID: 10603954 [No Abstract] [Full Text] [Related]
43. Altered dose response to beta-agonists in SERCA1a-expressing hearts ex vivo and in vivo. Huke S; Prasad V; Nieman ML; Nattamai KJ; Grupp IL; Lorenz JN; Periasamy M Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H958-65. PubMed ID: 12181124 [TBL] [Abstract][Full Text] [Related]
44. [Molecular mechanism of excitation and contraction in cardiac muscle]. Sugi H Nihon Rinsho; 1993 May; 51(5):1127-32. PubMed ID: 8331780 [TBL] [Abstract][Full Text] [Related]
45. Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state. Zhao W; Frank KF; Chu G; Gerst MJ; Schmidt AG; Ji Y; Periasamy M; Kranias EG Cardiovasc Res; 2003 Jan; 57(1):71-81. PubMed ID: 12504816 [TBL] [Abstract][Full Text] [Related]
46. Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy. Tang T; Gao MH; Roth DM; Guo T; Hammond HK Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H1906-12. PubMed ID: 15242835 [TBL] [Abstract][Full Text] [Related]
47. Calmodulin, a possible regulator of calcium transport in cardiac sarcoplasmic reticulum. Lopaschuk G; Katz S Proc West Pharmacol Soc; 1980; 23():25-8. PubMed ID: 7403139 [No Abstract] [Full Text] [Related]
48. cAMP-mediated signal transduction and sarcoplasmic reticulum function in heart failure. Movsesian MA Ann N Y Acad Sci; 1998 Sep; 853():231-9. PubMed ID: 10603951 [TBL] [Abstract][Full Text] [Related]
49. Phospholamban: a promising therapeutic target in heart failure? Schmidt AG; Edes I; Kranias EG Cardiovasc Drugs Ther; 2001 Sep; 15(5):387-96. PubMed ID: 11855657 [TBL] [Abstract][Full Text] [Related]
54. Discovery of phospholamban. A personal history. Katz AM Ann N Y Acad Sci; 1998 Sep; 853():9-19. PubMed ID: 10603932 [TBL] [Abstract][Full Text] [Related]
55. Phospholamban gene dosage effects in the mammalian heart. Luo W; Wolska BM; Grupp IL; Harrer JM; Haghighi K; Ferguson DG; Slack JP; Grupp G; Doetschman T; Solaro RJ; Kranias EG Circ Res; 1996 May; 78(5):839-47. PubMed ID: 8620604 [TBL] [Abstract][Full Text] [Related]
56. Early abnormalities in myocardial cell function in experimental diabetes. Gøtzsche O Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 2():1-21. PubMed ID: 3017048 [No Abstract] [Full Text] [Related]
57. Increased Na(+)-Ca(2+) exchanger in the failing heart. Pogwizd SM Circ Res; 2000 Oct; 87(8):641-3. PubMed ID: 11029397 [No Abstract] [Full Text] [Related]
58. [Contractile capacity of bundles of glycerinated fibers, calcium binding and absorption by fragmented myocardial sarcoplasmic reticulum following hypothalamic stimulation]. Karsanov NV; Khrapov VS; Kartvelishvili ; Tedeeva ZD; Khugashvili ZG Fiziol Zh (1978); 1981; 27(2):253-5. PubMed ID: 7238933 [No Abstract] [Full Text] [Related]
59. [Changes in resistance of Ca-transporting system of myocardial sarcoplasmic reticulum during "urgent"and "long-term" adaptation to physical load]. Golantsova NE; Sazontova TG Biull Eksp Biol Med; 1998 Jan; 125(1):40-4. PubMed ID: 9532365 [No Abstract] [Full Text] [Related]
60. Thermodynamic limitation for the sarcoplasmic reticulum Ca(2+)-ATPase contributes to impaired contractile reserve in hearts. Tian R Ann N Y Acad Sci; 1998 Sep; 853():322-4. PubMed ID: 10603970 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]